2025
The 2024 US Medical Eligibility Criteria for Contraceptive Use: Application to Practice in the Care of Patients With Cardiac Disease
Shapero K, Madden T. The 2024 US Medical Eligibility Criteria for Contraceptive Use: Application to Practice in the Care of Patients With Cardiac Disease. Circulation Research 2025, 136: 566-582. PMID: 40080533, DOI: 10.1161/circresaha.125.325682.Peer-Reviewed Original ResearchMeSH KeywordsContraceptionEligibility DeterminationFemaleHeart DiseasesHumansIntrauterine DevicesPregnancyUnited StatesConceptsCardiac disease statesCardiac diseaseIntrauterine deviceMedical Eligibility Criteria for Contraceptive UseContraceptive methodsUS Medical Eligibility CriteriaContraceptive useEffective reversible contraceptive methodsProgestin-only methodsMedical Eligibility CriteriaAssociated with increased riskReversible contraceptive methodsAcquired heart diseaseUS Centers for Disease Control and PreventionDisease statesCenters for Disease Control and PreventionDisease Control and PreventionContraceptive counselingControl and PreventionMaternal mortalityCare of patientsUnplanned pregnancyEligibility criteriaPatientsHeart disease
2023
Complications of Long-Acting Reversible Contraceptive Modalities
Irgens-Moller N, Baum C. Complications of Long-Acting Reversible Contraceptive Modalities. Pediatric Emergency Care 2023, 39: 443-449. PMID: 37256282, DOI: 10.1097/pec.0000000000002970.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentChildContraceptionContraceptive AgentsContraceptive Agents, FemaleFemaleHumansIntrauterine DevicesUnited StatesConceptsAdolescent populationPediatric emergency department settingEmergency department settingCommon complicationEtonogestrel implantsSafety profileContraceptive modalitiesDepartment settingReversible contraceptionCommon modalityInitial evaluationComplicationsModalitiesContraceptionExcellent effectivenessNexplanonPopulation
2019
Familiarity and acceptability of long-acting reversible contraception and contraceptive choice
Paul R, Huysman B, Maddipati R, Madden T. Familiarity and acceptability of long-acting reversible contraception and contraceptive choice. American Journal Of Obstetrics And Gynecology 2019, 222: s884.e1-s884.e9. PMID: 31838124, PMCID: PMC7781163, DOI: 10.1016/j.ajog.2019.11.1266.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsBlack or African AmericanChoice BehaviorContraceptive Agents, HormonalContraceptives, OralDelayed-Action PreparationsDrug ImplantsFemaleHealth Knowledge, Attitudes, PracticeHispanic or LatinoHumansIntrauterine DevicesLong-Acting Reversible ContraceptionMarital StatusMedroxyprogesterone AcetateMiddle AgedPatient Acceptance of Health CareRecognition, PsychologyWhite PeopleYoung AdultConceptsOral contraceptive pillsContraceptive pillsIntrauterine deviceDepo-medroxyprogesteroneContraceptive choicesReversible contraceptionDepo-medroxyprogesterone acetateHealth center populationHealthcare provider visitsHormonal intrauterine deviceHigh acceptabilityMultivariable Poisson regressionQualified health centersPreference-sensitive decisionsReversible contraception methodsCopper intrauterine deviceInterviewer-administered surveySpecific contraceptive methodsChi-square testProvider visitsContraceptive counselingContraceptive careHealth centersContraception methodsContraceptive methods
2017
Meeting the Contraceptive Needs of a Community: Increasing Access to Long-Acting Reversible Contraception.
McNicholas C, Madden T. Meeting the Contraceptive Needs of a Community: Increasing Access to Long-Acting Reversible Contraception. Missouri Medicine 2017, 114: 163-167. PMID: 30228573, PMCID: PMC6140203.Peer-Reviewed Original Research
2015
Accuracy of information about the intrauterine device on the Internet
Madden T, Cortez S, Kuzemchak M, Kaphingst K, Politi M. Accuracy of information about the intrauterine device on the Internet. American Journal Of Obstetrics And Gynecology 2015, 214: 499.e1-499.e6. PMID: 26546848, PMCID: PMC4808607, DOI: 10.1016/j.ajog.2015.10.928.Peer-Reviewed Original ResearchMeSH KeywordsConsumer Health InformationFemaleHumansInternetIntrauterine DevicesParityPatient SelectionPelvic Inflammatory DiseasePregnancySafetyConceptsWeb sitesQuality of informationCommon search enginesMost Web sitesWorld Wide Web sitesSearch enginesInternetQuarter of sitesOutdated informationInternet resourcesAccuracy of informationSafety of IUDsOnline sourcesInaccurate informationOnline searchHealth informationInformationAccurate informationSearchEffective methodInconsistent qualityDevicesEngineQualityAccuracyContraceptive Use and Unintended Pregnancy in Women With Congenital Heart Disease
Lindley K, Madden T, Cahill A, Ludbrook P, Billadello J. Contraceptive Use and Unintended Pregnancy in Women With Congenital Heart Disease. Obstetrics And Gynecology 2015, 126: 363-369. PMID: 26241427, DOI: 10.1097/aog.0000000000000911.Peer-Reviewed Original ResearchMeSH KeywordsAdultAttitude to HealthContraceptionContraception BehaviorContraceptive AgentsCross-Sectional StudiesFemaleHeart Defects, CongenitalHumansIntrauterine DevicesNeeds AssessmentPregnancyPregnancy Complications, CardiovascularPregnancy, UnplannedReproductive HistorySex CounselingSexual BehaviorUnited StatesConceptsCongenital heart diseaseHeart diseaseUnintended pregnancyReversible contraceptionContraceptive useCongenital heart disease clinicCross-sectional studyTime of conceptionDisease clinicPrimary outcomeTotal pregnanciesPregnancy historyActive womenIntrauterine deviceCardiology practiceContraceptive methodsHigh incidenceSubdermal implantsContraception useMost womenPregnancySpecific counselingContraceptionDiseaseWomenPositive Testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease in IUD Users
Birgisson N, Zhao Q, Secura G, Madden T, Peipert J. Positive Testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease in IUD Users. Journal Of Women's Health 2015, 24: 354-359. PMID: 25836384, PMCID: PMC4440993, DOI: 10.1089/jwh.2015.5190.Peer-Reviewed Original ResearchConceptsPelvic inflammatory diseaseChlamydia trachomatisIUD usersInflammatory diseasesIUD useIntrauterine deviceContraceptive methodsSelf-reported pelvic inflammatory diseaseNew IUD usersNeisseria gonorrhoeaeMajor public health problemProspective cohort studyHigh-risk womenPublic health problemYears of ageContraceptive CHOICE ProjectBirth control methodsCohort studyWomen 14Subsequent infertilityUnintended pregnancyReversible contraceptionHigh riskPID ratesPositive testingPreventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review
Birgisson N, Zhao Q, Secura G, Madden T, Peipert J. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review. Journal Of Women's Health 2015, 24: 349-353. PMID: 25825986, PMCID: PMC4441000, DOI: 10.1089/jwh.2015.5191.Peer-Reviewed Original ResearchConceptsContraceptive CHOICE ProjectUnintended pregnancyLARC methodsRepeat abortionProspective cohort studyTeen pregnancyReversible contraceptive methodsCHOICE ProjectYears of ageNon-LARC methodsNon-LARC usersHealth care systemContraceptive method choiceWomen 14Cohort studyContraceptive counselingEffective contraceptionLARC usersContraceptive methodsPregnancyStudy participantsNational ratesGreater continuationCare systemAccess barriersThe role of contraceptive attributes in women’s contraceptive decision making
Madden T, Secura G, Nease R, Politi M, Peipert J. The role of contraceptive attributes in women’s contraceptive decision making. American Journal Of Obstetrics And Gynecology 2015, 213: 46.e1-46.e6. PMID: 25644443, PMCID: PMC4485538, DOI: 10.1016/j.ajog.2015.01.051.Peer-Reviewed Original Research
2014
The Contraceptive CHOICE Project Round Up
MCNICHOLAS C, MADDEN T, SECURA G, PEIPERT J. The Contraceptive CHOICE Project Round Up. Clinical Obstetrics & Gynecology 2014, 57: 635-643. PMID: 25286295, PMCID: PMC4216614, DOI: 10.1097/grf.0000000000000070.Peer-Reviewed Original ResearchMeSH KeywordsAbortion, InducedAdolescentAdultCohort StudiesContraceptive Agents, FemaleContraceptive Devices, FemaleCounselingFamily Planning ServicesFemaleHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityHumansIntrauterine DevicesPregnancyPregnancy, UnplannedProspective StudiesTreatment OutcomeYoung AdultProvision of No-Cost, Long-Acting Contraception and Teenage Pregnancy
Secura G, Madden T, McNicholas C, Mullersman J, Buckel C, Zhao Q, Peipert J. Provision of No-Cost, Long-Acting Contraception and Teenage Pregnancy. New England Journal Of Medicine 2014, 371: 1316-1323. PMID: 25271604, PMCID: PMC4230891, DOI: 10.1056/nejmoa1400506.Peer-Reviewed Original ResearchConceptsRate of pregnancyReversible contraceptionLARC methodsLarge prospective cohort studyTeenage pregnancyProspective cohort studyReversible contraceptive methodsYears of ageTeenage girlsSame age groupHealth care costsContraceptive CHOICE ProjectCohort studyUnintended pregnancyIntrauterine deviceContraceptive methodsPregnancyWomen 15Care costsAge groupsNational ratesContraceptionTeenage birthsExperienced teensBirthIntrauterine devices and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer Consortium
Felix AS, Gaudet MM, La Vecchia C, Nagle CM, Shu XO, Weiderpass E, Adami HO, Beresford S, Bernstein L, Chen C, Cook LS, De Vivo I, Doherty JA, Friedenreich CM, Gapstur SM, Hill D, Horn‐Ross P, Lacey JV, Levi F, Liang X, Lu L, Magliocco A, McCann SE, Negri E, Olson SH, Palmer JR, Patel AV, Petruzella S, Prescott J, Risch HA, Rosenberg L, Sherman ME, Spurdle AB, Webb PM, Wise LA, Xiang Y, Xu W, Yang HP, Yu H, Zeleniuch‐Jacquotte A, Brinton LA. Intrauterine devices and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer Consortium. International Journal Of Cancer 2014, 136: e410-e422. PMID: 25242594, PMCID: PMC4267918, DOI: 10.1002/ijc.29229.Peer-Reviewed Original ResearchConceptsEndometrial Cancer ConsortiumEndometrial cancer riskIntrauterine deviceEC riskPooled analysisCancer riskLast useCancer ConsortiumOlder ageUse of IUDsMultivariable logistic regressionConfidence intervalsPooled odds ratioCase-control studyInert intrauterine deviceDuration of useHeavy bleedingOdds ratioReversible contraceptivesHormonal changesEC casesReduced riskBiologic effectsUterine environmentLogistic regressionPerformance of a checklist to exclude pregnancy at the time of contraceptive initiation among women with a negative urine pregnancy test
Min J, Buckel C, Secura G, Peipert J, Madden T. Performance of a checklist to exclude pregnancy at the time of contraceptive initiation among women with a negative urine pregnancy test. Contraception 2014, 91: 80-84. PMID: 25218500, PMCID: PMC4267981, DOI: 10.1016/j.contraception.2014.08.002.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultChecklistCohort StudiesContraceptive Agents, FemaleContraindicationsDrug ImplantsFalse Negative ReactionsFemaleHumansIllinoisIntrauterine DevicesLuteal PhaseMiddle AgedMissouriPatient CompliancePregnancyPregnancy TestsPregnancy Trimester, FirstPregnancy, UnplannedProspective StudiesSensitivity and SpecificityYoung AdultConceptsNegative urine pregnancy testUrine pregnancy testLuteal phase pregnanciesNegative predictive valuePregnancy checklistPregnancy testPositive predictive valuePredictive valueContraceptive initiationEarly pregnancyPositive urine pregnancy testHigh negative predictive valueInitiation of contraceptionSame-day initiationUrine pregnancy testingDays of enrollmentProspective cohort studyShort acting methodsContraceptive CHOICE ProjectCohort studyPositive screenReversible contraceptionPatient historyIntrauterine devicePregnancy testingAssociation of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction
Diedrich J, Desai S, Zhao Q, Secura G, Madden T, Peipert J. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction. American Journal Of Obstetrics And Gynecology 2014, 212: 50.e1-50.e8. PMID: 25046805, PMCID: PMC4275360, DOI: 10.1016/j.ajog.2014.07.025.Peer-Reviewed Original Research
2013
Twenty-Four–Month Continuation of Reversible Contraception
O'Neil-Callahan M, Peipert J, Zhao Q, Madden T, Secura G. Twenty-Four–Month Continuation of Reversible Contraception. Obstetrics And Gynecology 2013, 122: 1083-1091. PMID: 24104781, PMCID: PMC4012225, DOI: 10.1097/aog.0b013e3182a91f45.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBody Mass IndexCohort StudiesContraceptionContraceptive Agents, FemaleContraceptives, OralFemaleFollow-Up StudiesHumansInterviews as TopicIntrauterine DevicesIntrauterine Devices, CopperLevonorgestrelMedroxyprogesterone AcetateParityProspective StudiesRisk FactorsSocioeconomic FactorsYoung AdultConceptsNon-LARC methodsContinuation ratesContraceptive CHOICE ProjectReversible contraceptionContraceptive methodsFirst-line contraceptive optionProspective observational cohort studyContraceptive method discontinuationImplant continuation ratesMonth continuation ratesObservational cohort studyMonths of enrollmentHigh continuation ratesReversible contraceptive methodsCHOICE ProjectShort-acting methodsCohort studyMethod discontinuationContraceptive optionsLARC methodsUnintended pregnancyIntrauterine deviceCost contraceptionLower riskCopper IUD
2012
Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate
Nault A, Peipert J, Zhao Q, Madden T, Secura G. Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate. American Journal Of Obstetrics And Gynecology 2012, 208: 48.e1-48.e8. PMID: 23103344, PMCID: PMC3974101, DOI: 10.1016/j.ajog.2012.10.876.Peer-Reviewed Original ResearchMeSH KeywordsAdultBody WeightContraceptive Agents, FemaleFemaleHumansIntrauterine DevicesMedroxyprogesterone AcetateSelf ConceptWeight GainCervical lidocaine for IUD insertional pain: a randomized controlled trial
McNicholas C, Madden T, Zhao Q, Secura G, Allsworth J, Peipert J. Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal Of Obstetrics And Gynecology 2012, 207: 384.e1-384.e6. PMID: 23107081, PMCID: PMC3492878, DOI: 10.1016/j.ajog.2012.09.018.Peer-Reviewed Original ResearchImmediate Postabortion Intrauterine Device Insertion: Continuation and Satisfaction
McNicholas C, Hotchkiss T, Madden T, Zhao Q, Allsworth J, Peipert J. Immediate Postabortion Intrauterine Device Insertion: Continuation and Satisfaction. Women's Health Issues 2012, 22: e365-e369. PMID: 22749197, PMCID: PMC3608473, DOI: 10.1016/j.whi.2012.04.008.Peer-Reviewed Original ResearchMeSH KeywordsAbortion, InducedAdolescentAdultFemaleFollow-Up StudiesHumansIntrauterine DevicesMiddle AgedPatient DropoutsPatient SatisfactionPostoperative ComplicationsPostoperative PeriodPregnancyPregnancy Trimester, FirstPregnancy Trimester, SecondRetrospective StudiesSocioeconomic FactorsSurveys and QuestionnairesUrban PopulationUterine HemorrhageYoung AdultConceptsIntrauterine deviceIUD insertionRetrospective cohort studyGreater gestational ageTime of abortionCohort studyGestational ageHigher parityUnintended pregnancyClinical dataIUD useProcedure notesSatisfaction rateIntake formsWomenShort questionnairePregnancyHigh ratePostabortionSatisfactionDemographicsContraceptive Failure Rates of Etonogestrel Subdermal Implants in Overweight and Obese Women
Xu H, Wade J, Peipert J, Zhao Q, Madden T, Secura G. Contraceptive Failure Rates of Etonogestrel Subdermal Implants in Overweight and Obese Women. Obstetrics And Gynecology 2012, 120: 21-26. PMID: 22678035, PMCID: PMC4043143, DOI: 10.1097/aog.0b013e318259565a.Peer-Reviewed Original ResearchConceptsObese womenContraceptive failure ratesIntrauterine deviceContraceptive methodsFirst-line contraceptive methodLarge prospective cohort studyKaplan-Meier survival curvesActing reversible contraceptive (LARC) methodsUrine pregnancy testingProspective cohort studyBody mass indexEtonogestrel subdermal contraceptive implantEtonogestrel subdermal implantSubdermal contraceptive implantFailure rateReversible contraceptive methodsT-testContraceptive CHOICE ProjectStudent's t-testReliable birth control methodsBirth control methodsCohort studyCumulative failure rateNormal weightMass indexEffectiveness of Long-Acting Reversible Contraception
Winner B, Peipert J, Zhao Q, Buckel C, Madden T, Allsworth J, Secura G. Effectiveness of Long-Acting Reversible Contraception. New England Journal Of Medicine 2012, 366: 1998-2007. PMID: 22621627, DOI: 10.1056/nejmoa1110855.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsCohort StudiesContraceptionContraceptive Devices, FemaleContraceptives, OralDrug ImplantsFemaleHumansInjectionsIntrauterine DevicesMedroxyprogesterone AcetateMiddle AgedMultivariate AnalysisPregnancyPregnancy, UnplannedTransdermal PatchTreatment OutcomeYoung AdultConceptsUnintended pregnancyReversible contraceptionContraceptive methodsLarge prospective cohort studyActing reversible contraceptive (LARC) methodsProspective cohort studyContraceptive failure ratesReversible contraceptive methodsYears of ageLong-Acting Reversible ContraceptionDMPA injectionOverall cohortCohort studyRate of failureContraceptive pillsContraceptive failurePregnancyYoung womenContraceptionPillsOlder participantsAgeFailure rateParticipantsRisk
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply